WebThe 3 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 4.00. The … WebCitius Pharmaceuticals Inc. on Wednesday said it filed for U.S. Food and Drug Administration approval of its lead product candidate denileukin diftitox, also known as I/Ontak, for the treatment of...
CTXR - Citius Pharmaceuticals, Inc. Stock Price and Quote
WebApr 11, 2024 · Citius Pharmaceuticals - CTXR Stock Forecast, Price & News $1.34 +0.17 (+14.53%) (As of 04/3/2024 04:00 PM ET) Compare Today's Range $1.17 $1.38 50-Day Range $0.98 $1.42 52-Week Range $0.77 $2.01 Volume 1.81 million shs Average Volume 843,413 shs Market Capitalization $195.99 million P/E Ratio N/A Dividend Yield … WebCTXR - Citius Pharmaceuticals Inc. Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. how to shower without showering
Citius Pharmaceuticals (CTXR) Price To Cash Flow - Zacks.com
WebJD.com stock price target cut to $45 from $62 at Susquehanna. Mar. 13, 2024 at 6:41 a.m. ET by Tomi Kilgore. WebCTXR Citius Pharmaceuticals Inc. Profile MarketWatch Citius Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch. Citius … WebApr 6, 2024 · CTXR Articles Average Week Source Sentiment All Sentiments This page (NASDAQ:CTXR) was last updated on 4/1/2024 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring how to shred a dress for halloween